Chronic lymphocytic leukemia with unusual cytoplasmic anomalies
figure
Recurred breast cancer presenting with autoimmune hemolytic anemia
figure
Do not jump to hasty conclusions: all gamma delta T-cells neoplasms are not aggressive!
figure
Blood Res 2019; 54(4): 241~295
Images of Hematology
Chronic lymphocytic leukemia with unusual cytoplasmic anomalies
Nicolas Athanase
Blood Res 2019; 54(4): 241-241  https://doi.org/10.5045/br.2019.54.4.241 PDF PubMed Central
Recurred breast cancer presenting with autoimmune hemolytic anemia
Joowon Park
Blood Res 2019; 54(4): 242-242  https://doi.org/10.5045/br.2019.54.4.242 PDF PubMed Central
Do not jump to hasty conclusions: all gamma delta T-cells neoplasms are not aggressive!
Fran?ois Vergez, Laetitia Largeaud, Lucie Oberic et al.
Blood Res 2019; 54(4): 243-243  https://doi.org/10.5045/br.2019.54.4.243 PDF PubMed Central
Original Articles
Clinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphoma
Do-Young Kim, Moo-Kon Song, Joo-Seop Chung et al.
Blood Res 2019; 54(4): 244-252  https://doi.org/10.5045/br.2019.54.4.244 PDF PubMed Central
Potential biomarkers and antagonists for fluoranthene-induced cellular toxicity of bone marrow derived mesenchymal stem cells
Md Moinul Hoque, Young Eun Lee, Hye Ran Kim et al.
Blood Res 2019; 54(4): 253-261  https://doi.org/10.5045/br.2019.54.4.253 PDF PubMed Central
Evaluating the effect of donor anxiety levels and lifestyle characteristics on the activation of platelet concentrates
Soner Yılmaz, ?brahim Eker, Elif El?i et al.
Blood Res 2019; 54(4): 262-268  https://doi.org/10.5045/br.2019.54.4.262 PDF PubMed Central
The increasing trend of blood donation in Iran
Moslem Taheri Soodejani, Ali Akbar Haghdoost, Abbas Sedaghat et al.
Blood Res 2019; 54(4): 269-273  https://doi.org/10.5045/br.2019.54.4.269 PDF PubMed Central
Original Articles
Clinical significance of T cell receptor excision circle (TREC) quantitation after allogenic HSCT
Neveen Lewis Mikhael, Manal Elsorady
Blood Res 2019; 54(4): 274-281  https://doi.org/10.5045/br.2019.54.4.274 PDF PubMed Central
Letters to the Editor
EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
Shruti Prem, David Loach, Jeffrey Lipton et al.
Blood Res 2019; 54(4): 282-284  https://doi.org/10.5045/br.2019.54.4.282 PDF PubMed Central
Retrospective screening for Philadelphia-negative myeloproliferative neoplasms in patients with cerebral infarctions as revealed using the revised 2016 World Health Organization diagnostic criteria
Ik-Chan Song, Yoon-Seok Choi, Jong Wook Shin et al.
Blood Res 2019; 54(4): 284-285  https://doi.org/10.5045/br.2019.54.4.284 PDF PubMed Central
Beta-2 microglobulin as a prognostic factor of primary central nervous system lymphoma
Jaewon Hyung, Jung Yong Hong, Shin Kim et al.
Blood Res 2019; 54(4): 285-288  https://doi.org/10.5045/br.2019.54.4.285 PDF PubMed Central
Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation
Pasquale Niscola, Carmen Di Grazia, Carla Mazzone et al.
Blood Res 2019; 54(4): 288-290  https://doi.org/10.5045/br.2019.54.4.288 PDF PubMed Central
Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning
Mihong Choi, Dong-Yeop Shin, Ji Yun Lee et al.
Blood Res 2019; 54(4): 290-295  https://doi.org/10.5045/br.2019.54.4.290 PDF PubMed Central

Current Issue

31 December 2019 Volume 54.
Number 4 pp. 241~295
ba_link01
Today : 99  /
Total : 181,644